Top compounds associated with response to CTSH


Feature Type Standardized
Nominal ANOVA
mRNA parbendazole CTRPv2 pan-cancer AAC -0.085 0.008
mRNA piperlongumine GDSC1000 pan-cancer AAC -0.093 0.008
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC -0.086 0.008
mRNA Gefitinib GDSC1000 pan-cancer AAC 0.094 0.009
mRNA BI-2536 CTRPv2 pan-cancer AAC -0.085 0.009
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.095 0.009
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC -0.09 0.009
mRNA BRD-K97651142 CTRPv2 pan-cancer AAC -0.099 0.01
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.09 0.01
mRNA YM201636 GDSC1000 pan-cancer AAC -0.087 0.01
Download CSV